How a joined-up development strategy pays off for early-stage biotechs
Parexel Biotech’s Nate Akers and Vicky Hsu discuss how important it is for biotechs to align clinical execution with a clearly defined regulatory strategy to increase the chance of success for a new drug program.
Related Insights
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Blog
Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development
Jan 22, 2025
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025
Related Insights
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Blog
Proof of product safety and efficacy: how to move ahead successfully in Phase 2 clinical development
Jan 22, 2025
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Playbook
Early-phase development strategies for navigating regulatory complexity in the EU
Apr 29, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Playbook
Streamlining development in the EU: Strategies for smoother CTA submissions
Feb 27, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Blog
Overcoming risks in Phase 3 trials to accelerate time to market
Jan 22, 2025
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Webinar
Regulatory roadmap for biotechs: Effective strategies for streamlined early phase development
May 6, 2025